Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.
"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.
Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.
John Simon, MD, is a big advocate for these elective exams, but the American College of Radiology and some members of the specialty oppose this practice.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
Tom Price, MD, an orthopedic surgeon, and former secretary of Health and Human Services (HHS) is an advocate for changing immigration policy to help solve the growing shortage of doctors and nurses in the U.S.
Arlene Sussman, MD, medical director with vRad, explains a telebreast imaging system that allows patients direct video consults with a remote radiologist just after their exams to increase personalized care and answer questions immediately.
Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.
